A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Clinical trial NCT00807677 · COMPLETED

Trial details

NCT number: NCT00807677
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Multiple Myeloma Waldenstrom's Macroglobulinemia Myelodysplastic Syndrome Philadelphia Chromosome-negative CML Myeloid Metaplasia Myelofibrosis Advanced Polycythemia Non-Hodgkins Lymphoma

Start date: 2009-03-01
Primary completion: 2012-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.